Annual Information Update

RNS Number : 2583O

Phytopharm PLC

03 March 2009

 



Phytopharm plc

Annual Information Update

Phytopharm plc (the Company) announces that, in accordance with the requirements of Prospectus Rule 5.2 issued by the Financial Services Authority, and following publication of the Annual Report on 28 January 2009, the following information has been published or made available to the public between 3 February 2008 and 3 March 2009 inclusive, in compliance with laws and rules dealing with the regulation of securities, issuers of securities and securities markets.

For the purpose of this update, only references to the information are provided. Full copies of each item can be found at the locations specified below. In accordance with the provisions of Article 27.3 of the Prospectus Directive Regulations, we confirm that to the best of our knowledge, information relating to 'Holdings in Company' and 'Director/PDMR Shareholdings' is up to date at the date of this announcement, but it is acknowledged that such disclosures may, at any time, become out of date, due to changing circumstances.

1.   Announcements made via Regulatory Information Services

All documents listed below were published via a regulatory information service on the dates indicated: 

Date of publication	Title
5 February 2008	Total voting rights
14 February 2008	Director / PDMR shareholding
18 February 2008	Interim management statement
28 February 2008	Notice of AGM
3 March 2008	Total voting rights
4 March 2008	Publication of prospectus
13 March 2008	Director / PDMR shareholding
25 March 2008	Placing and open offer
27 March 2008	Result of AGM
27 March 2008	Result of AGM
28 March 2008	Director / PDMR shareholding
28 March 2008	Director / PDMR shareholding
28 March 2008	Director / PDMR shareholding
28 March 2008	Director / PDMR shareholding
28 March 2008	Director / PDMR shareholding
28 March 2008	Director / PDMR shareholding
28 March 2008	Director / PDMR shareholding
28 March 2008	Holdings in Company
1 April 2008	Total voting rights
2 April 2008	Holdings in Company
4 April 2008	Holdings in Company
4 April 2008	Holdings in Company
4 April 2008	Holdings in Company
4 April 2008	Holdings in Company
4 April 2008	Holdings in Company
4 April 2008	Holdings in Company
4 April 2008	Holdings in Company
9 April 2008	Holdings in Company
14 April 2008	Holdings in Company
14 April 2008	Holdings in Company
14 April 2008	Director / PDMR shareholding
1 May 2008	Total voting rights
2 May 2008	Block listing review
12 May 2008	Director / PDMR shareholding
16 May 2008	Notice of interim results
21 May 2008	Myogane™ granted EU Orphan drug status
29 May 2008	Interim results
3 June 2008	Director / PDMR shareholding
3 June 2008	Director / PDMR shareholding
4 June 2008	Total voting rights
11 June 2008	Product launch
13 June 2008	Director / PDMR shareholding
3 July 2008	Interim management statement
9 July 2008	Director / PDMR shareholding
21 July 2008	Price monitoring extension
8 August 2008	Director / PDMR shareholding
10 September 2008	Director / PDMR shareholding
9 October 2008	Director / PDMR shareholding
5 November 2008	Block listing interim review
11 November 2008	Director / PDMR shareholding
13 November 2008	Board change
14 November 2008	Trading statement
27 November 2008	Final results
12 December 2008	Portfolio update
19 December 2008	Price monitoring extension
19 December 2008	Second price monitoring extension
28 January 2009	Annual report and accounts & notice of AGM
17 February 2009	Interim management statement
17 February 2009	Holdings in Company
19 February 2009	Holdings in Company

2. Documents published or sent to Shareholders or filed with the UK Listing Authority or submitted to the FSA

Date of publication	Title
28 February 2008	Notice of AGM
28 February 2008	Prospectus and notice of EGM
28 February 2008	Form 1 Application for admission of securities to trading
28 February 2008	Application for admission of securities to the Official List
28 March 2008	Special resolutions passed at AGM
28 March 2008	Special resolutions passed at EGM
29 January 2009	Annual report 2008
29 January 2009	Notice of AGM

Certain documents submitted to the FSA can be viewed at the Document Viewing Facility situated at the Financial Services Authority, 25 The North Colonnade, Canary Wharf, London E14 5HS

The 2008 Interim and 2008 Annual reports are also available on the Company's website www.phytopharm.com

3. Documents filed at Companies House

The Company has submitted the following filings to Companies House:

Date of Publications	Title
14 January 2008	Form 363 Annual Return
24 January 2008	Form 88(2) Return of Allotments of Shares
13 February 2008	Form 88(2) Return of Allotments of Shares
13 March 2008	Form 88(2) Return of Allotments of Shares
28 March 2008	Special resolutions passed at AGM
28 March 2008	Special resolution passed at EGM
28 March 2008	Form 123 Notice of Increase in Nominal Capital
28 March 2008	Articles of Association
2 April 2008	Form 88(2) Return of Allotments of Shares
14 April 2008	Form 88(2) Return of Allotments of Shares
13 May 2008	Form 88(2) Return of Allotment of Shares
2 July 2008	Form 288b Terminating appointment of Company Secretary
2 July 2008	Form 288a Appointment of Company Secretary
14 November 2008	Form 288b Terminating appointment of Director - Dr D Rees
14 November 2008	288b Terminating appointment of Director - Mr P Morgan
10 December 2008	Form 363 Annual Return
21 January 2009	Form 353a Notice of place for inspection of a register of members
29 January 2009	Annual report and accounts for the year ended 30 September 2008

Copies of these documents can be obtained from Companies House, Crown Way, Cardiff CF14 3UZ (Telephone [phone], email at enquiries @companies-house.gov.uk) or, if you are a registered user, through Companies House Direct at www.companies-house.gov.uk

Copies of all documents referred to above are also available for inspection at the Company's registered office (Corpus Christi House, 9 West Street, Godmanchester, Cambs PE29 2HY, United Kingdom) during normal business hours or by request from the Company Secretary.

For further information, please contact:

Zoe McGowan, Head of Finance

Phytopharm plc Tel No: [phone]

Further information about Phytopharm can be found on the Company's website www.phytopharm.com

 

END

 

 

AIUEAKDDESFNEFE